Target intelligence / Profile preview

Calcium-transporting ATPase type 2C member 2 (SPCA2)

Target
SPCA2
Molecular classification
Enzyme, P-type ATPase, Ion transporter
01

Overview

Calcium-transporting ATPase type 2C member 2 (SPCA2, gene symbol ATP2C2) is a P-type ATPase enzyme and ion transporter localized primarily in the Golgi apparatus membranes. It uses ATP hydrolysis to pump calcium and manganese ions from the cytosol into the Golgi lumen, thus playing critical roles in maintaining cytosolic calcium and manganese homeostasis, supporting processing and trafficking of newly synthesized proteins, and contributing to specialized physiological functions such as milk secretion in the mammary gland[1][2][6]. SPCA2 is implicated in disease states including autism spectrum disorder and triple-receptor negative breast cancer. It may regulate mitochondrial respiration, the cellular response to DNA damage, and can interact with plasma membrane calcium channels to facilitate calcium entry independently of organelle stores[1][2][5][6].

Other names
SPCA2 (Secretory pathway Ca2+-ATPase 2)ATP2C2 (gene symbol)Calcium pump 2Secretory pathway calcium ATPase 2
02

Mechanism of action

For hypothetical drugs targeting this molecule: - Inhibition: would reduce Golgi calcium/manganese loading, potentially impairing protein processing or secretion (INFERRED). - Activation/enhancement: would support calcium/manganese sequestration, possibly limiting cytosolic toxicity and supporting protein maturation in secretory cells (INFERRED).

03

Biological functions

Calcium ion transmembrane transportManganese ion transmembrane transportIntracellular calcium homeostasisProtein processing and trafficking in the Golgi apparatusRegulation of mitochondrial respiration and DNA damage responsePositive regulation of calcium ion importMammary gland epithelium development (especially in milk secretion)
04

Disease associations

Autism spectrum disorderTriple-negative breast cancerPotential roles in other disorders linked to calcium homeostasis and manganese toxicity
05

Safety considerations

Disruption of SPCA2 function could lead to cytosolic calcium or manganese toxicity, altered protein secretion, and neurological or secretory pathology; therapeutic targeting presents risks of cellular dysfunction, especially in tissues with high secretory activity such as mammary glands
06

Interacting drugs

No FDA-approved drugs directly target SPCA2/ATP2C2 as a primary therapeutic mechanism, but modulation of calcium channels, ion transporters, and related transport mechanisms is pharmacologically relevant. Drugs affecting cellular calcium may indirectly influence this pump's effects (INFERRED; no direct evidence in search results)
07

Biomarkers

ATP2C2 expression or activity could potentially serve as biomarkers for breast cancer subtypes or calcium homeostasis disturbances—but no clinically validated biomarkers for patient selection or drug monitoring are currently confirmed in search results

Beyond the preview

Go deeper on Calcium-transporting ATPase type 2C member 2 (SPCA2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calcium-transporting ATPase type 2C member 2 (SPCA2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call